Ironwood Pharmaceuticals ... (IRWD)
NASDAQ: IRWD
· Real-Time Price · USD
1.08
0.01 (0.93%)
At close: Aug 15, 2025, 12:37 PM
Ironwood Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -37.39M | 2.26M | 3.65M | -860K | -4.16M | -1.09M | 13.95M | -1.09B | 45.71M | 48.87M | 50.32M | 37.08M | 38.8M | 41.37M | 55.84M | 391.3M | 39.93M |
Depreciation & Amortization | 479K | 485K | 507K | 506K | 513K | 512K | 507K | 270K | 286K | 340K | 363K | 360K | 355K | 359K | 358K | 396K | 410K |
Stock-Based Compensation | 5.29M | 4.57M | 8.33M | 8.57M | 8.38M | 8.7M | 7.91M | 8.26M | 7.13M | 7.29M | 7.07M | 6.6M | 6.09M | 6.09M | 6.21M | 4.59M | 5.4M |
Other Working Capital | -1.71M | -22.18M | 7.39M | -502K | -11M | 8.58M | -5.78M | 578K | -15M | 3.21M | 4.76M | 1.88M | -6.9M | 14.45M | 2.08M | -1.28M | 514.64M |
Other Non-Cash Items | 825K | 415K | 355K | 587K | 622K | 4.93M | 586K | 1.06B | 383K | 420K | 249K | 516K | -193K | 8.71M | 3.95M | 5.93M | 5.82M |
Deferred Income Tax | 670K | 41.1M | 7.68M | 13.26M | 6.05M | 31.32M | 14.26M | 10.01M | 17.05M | 20.13M | 16.02M | 14.89M | 14.71M | 1.93M | 2.57M | -334.63M | -2.37M |
Change in Working Capital | 50.08M | -33.61M | -10.63M | 11.41M | 33.58M | -8.54M | -4.75M | 14.96M | 9.61M | 2.13M | -4.92M | 1.24M | 4.36M | 6.1M | 6.13M | -19.01M | 24.51M |
Operating Cash Flow | 19.95M | 15.21M | 9.88M | 33.47M | 44.98M | 35.83M | 32.46M | 34.96M | 80.17M | 79.18M | 69.09M | 61.37M | 64.12M | 64.57M | 75.06M | 48.57M | 73.69M |
Capital Expenditures | -31K | -16K | -16K | -58K | -68K | -211K | -49K | n/a | -13K | 27K | -66K | -88K | -9K | -128K | -137K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -3.98M | -22.58M | -999.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -31K | -16K | -16K | -58K | -68K | -4.19M | -22.63M | -999.49M | -13K | 27K | -66K | -88K | -9K | -128K | -137K | n/a | n/a |
Debt Repayment | n/a | 100M | -25M | -50M | -25M | -25M | -75M | 400M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -33.9M | -92.5M | -24.13M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -114.14M | -2.16M | -121K | -616K | -26.9M | n/a | -929K | 3.98M | 2.81M | 797K | -116.38M | 1.62M | -18.59M | 6.16M | 5.66M | 2.21M |
Financial Cash Flow | 6K | -14.89M | -27.16M | -49.37M | -15.55M | -50.9M | -74.99M | 399.07M | 3.98M | 2.81M | 797K | -150.28M | -90.87M | -18.59M | 6.16M | 5.66M | 2.21M |
Net Cash Flow | 19.92M | 348K | -17.31M | -16.02M | 29.39M | -19.31M | -65.16M | -565.46M | 84.14M | 82.02M | 69.82M | -89.01M | -26.76M | 45.85M | 81.09M | 54.23M | 75.91M |
Free Cash Flow | 19.92M | 15.21M | 9.87M | 33.41M | 44.92M | 35.62M | 32.41M | 34.96M | 80.16M | 79.21M | 69.03M | 61.28M | 64.11M | 64.44M | 74.93M | 48.57M | 73.69M |